Company Filing History:
1 out of 119 
1 out of 26 
1 out of 2 Years Active: 2025
Title: Innovations of Hongming Liang in Pharmaceutical Development
Introduction
Hongming Liang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemophagocytic syndrome. His innovative work has led to the development of a unique compound that holds promise for patients suffering from this condition.
Latest Patents
Hongming Liang holds 1 patent for his invention titled "Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome." This patent focuses on the application of a pyrrolopyrimidine compound, specifically a compound of formula (I), its stereoisomers, or pharmaceutically acceptable salts, in the treatment of hemophagocytic syndrome. This advancement represents a significant step forward in therapeutic options for this serious medical condition.
Career Highlights
Throughout his career, Hongming Liang has worked with prominent pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Hongming Liang has collaborated with esteemed colleagues such as Xiquan Zhang and Xunqiang Wang. These partnerships have fostered an environment of innovation and have been instrumental in advancing their shared goals in pharmaceutical research.
Conclusion
In summary, Hongming Liang's contributions to the field of pharmaceuticals, particularly through his patent for treating hemophagocytic syndrome, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic solutions in medicine.